{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:27:12Z","timestamp":1769833632724,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00063-024-01153-9","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T23:08:56Z","timestamp":1720566536000},"page":"290-299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Extrakorporale Erregerelimination mit biomimetischem Adsorber\u00a0\u2013 eine neue Therapiestrategie f\u00fcr die Intensivmedizin","Extracorporeal removal of pathogens using a\u00a0biomimetic adsorber\u2014A\u00a0new treatment strategy for the intensive care unit"],"prefix":"10.1007","volume":"120","author":[{"given":"Malin-Theres","family":"Seffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8110-9064","authenticated-orcid":false,"given":"Jan T.","family":"Kielstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"issue":"9","key":"1153_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/BF01695896","volume":"59","author":"F Keller","year":"1981","unstructured":"Keller\u00a0F, Feldmann\u00a0K, Abshagen\u00a0U, Hennemann\u00a0H, Barz\u00a0R (1981) Diagnostic haemoperfusion for rapid detection of bacteremia. First clinical results of a\u00a0comparison with the conventional blood culture technique. Klin Wochenschr 59(9):425\u2013429","journal-title":"Klin Wochenschr"},{"key":"1153_CR2","doi-asserted-by":"crossref","unstructured":"Keller F, Feldmann K, Gaugler B, Besenfelder E: [Investigation of the viability of radioactively labelled bacteria after adsorption on activated charcoal (author\u2019s transl)]. Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol 1981, 250(1\u20132):113\u2013121.","DOI":"10.1016\/S0174-3031(81)80169-2"},{"issue":"1","key":"1153_CR3","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41467-018-02879-9","volume":"9","author":"L Liu","year":"2018","unstructured":"Liu\u00a0L, Chen\u00a0S, Xue\u00a0Z, Zhang\u00a0Z, Qiao\u00a0X, Nie\u00a0Z, Han\u00a0D, Wang\u00a0J, Wang\u00a0T (2018) Bacterial capture efficiency in fluid bloodstream improved by bendable nanowires. Nat Commun 9(1):444","journal-title":"Nat Commun"},{"issue":"1","key":"1153_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/nl3047305","volume":"14","author":"JJ Lee","year":"2014","unstructured":"Lee\u00a0JJ, Jeong\u00a0KJ, Hashimoto\u00a0M, Kwon\u00a0AH, Rwei\u00a0A, Shankarappa\u00a0SA, Tsui\u00a0JH, Kohane\u00a0DS (2014) Synthetic ligand-coated magnetic nanoparticles for microfluidic bacterial separation from blood. Nano Lett 14(1):1\u20135","journal-title":"Nano Lett"},{"issue":"1","key":"1153_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000167011","volume":"27","author":"RH Tullis","year":"2009","unstructured":"Tullis\u00a0RH, Duffin\u00a0RP, Handley\u00a0HH, Sodhi\u00a0P, Menon\u00a0J, Joyce\u00a0JA, Kher\u00a0V (2009) Reduction of hepatitis\u00a0C virus using lectin affinity plasmapheresis in dialysis patients. Blood Purif 27(1):64\u201369","journal-title":"Blood Purif"},{"key":"1153_CR6","doi-asserted-by":"publisher","first-page":"744141","DOI":"10.3389\/fmed.2021.744141","volume":"8","author":"DE Amundson","year":"2021","unstructured":"Amundson\u00a0DE, Shah\u00a0US, de Necochea-Campion\u00a0R, Jacobs\u00a0M, LaRosa\u00a0SP, Fisher\u00a0CJ Jr. (2021) Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier(R) Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection. Front Med (lausanne) 8:744141","journal-title":"Front Med (lausanne)"},{"key":"1153_CR7","doi-asserted-by":"crossref","unstructured":"Larm O, Larsson R, Olsson P: A\u00a0new non-thrombogenic surface prepared by selective covalent binding of heparin via a\u00a0modified reducing terminal residue. Biomater Med Devices Artif Organs 1983, 11(2\u20133):161\u2013173.","DOI":"10.3109\/10731198309118804"},{"issue":"6","key":"1153_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.4014\/jmb.1102.02016","volume":"21","author":"I Mattsby-Baltzer","year":"2011","unstructured":"Mattsby-Baltzer\u00a0I, Bergstrom\u00a0T, McCrea\u00a0K, Ward\u00a0R, Adolfsson\u00a0L, Larm\u00a0O (2011) Affinity apheresis for treatment of bacteremia caused by Staphylococcus aureus and\/or methicillin-resistant S.\u00a0aureus (MRSA). J\u00a0Microbiol Biotechnol 21(6):659\u2013664","journal-title":"J Microbiol Biotechnol"},{"issue":"12","key":"1153_CR9","doi-asserted-by":"publisher","first-page":"e114242","DOI":"10.1371\/journal.pone.0114242","volume":"9","author":"K McCrea","year":"2014","unstructured":"McCrea\u00a0K, Ward\u00a0R, LaRosa\u00a0SP (2014) Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion media. Plos One 9(12):e114242","journal-title":"Plos One"},{"issue":"3","key":"1153_CR10","doi-asserted-by":"publisher","first-page":"e0283304","DOI":"10.1371\/journal.pone.0283304","volume":"18","author":"MT Seffer","year":"2023","unstructured":"Seffer\u00a0MT, Weinert\u00a0M, Molinari\u00a0G, Rohde\u00a0M, Grobe\u00a0L, Kielstein\u00a0JT, Engelmann\u00a0S (2023) Staphylococcus aureus binding to Seraph(R) 100 Microbind(R) Affinity Filter: Effects of surface protein expression and treatment duration. PLoS ONE 18(3):e283304","journal-title":"PLoS ONE"},{"key":"1153_CR11","doi-asserted-by":"crossref","unstructured":"Lacquaniti AS, A.; Campo, S.; La Camera, E.; Lanteri, G.; Giunta, E.; Monardo, P.; Trombetta, D.: In Vitro Simulated Hemoperfusion on Seraph\u00ae-100 as a\u00a0Promising Strategy to Counteract Sepsis. Biomedicines 2024, 12.","DOI":"10.3390\/biomedicines12030575"},{"issue":"1","key":"1153_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/MAT.0b013e3181c3fec8","volume":"56","author":"J Axelsson","year":"2010","unstructured":"Axelsson\u00a0J, Ferreira\u00a0M, Adolfsson\u00a0L, McCrea\u00a0K, Ward\u00a0R, Larm\u00a0O (2010) Cytokines in blood from septic patients interact with surface-immobilized heparin. ASAIO\u00a0J 56(1):48\u201351","journal-title":"ASAIO J"},{"key":"1153_CR13","doi-asserted-by":"crossref","unstructured":"Seffer MT, Cottam D, Forni LG, Kielstein JT (2020) Heparin 2.0: A\u00a0New Approach to the Infection Crisis. Blood Purif: 1\u20137","DOI":"10.1159\/000508647"},{"key":"1153_CR14","doi-asserted-by":"crossref","unstructured":"Ebeyer-Masotta M, Eichhorn T, Weiss R, Semak V, Laukova L, Fischer MB, Weber V (2022) Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4, High-Mobility Group Box 1 Protein and Histones. Int J Mol Sci 23(3)","DOI":"10.3390\/ijms23031823"},{"issue":"1","key":"1153_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jchromb.2008.03.023","volume":"867","author":"M Kenig","year":"2008","unstructured":"Kenig\u00a0M, Gaberc-Porekar\u00a0V, Fonda\u00a0I, Menart\u00a0V (2008) Identification of the heparin-binding domain of TNF-alpha and its use for efficient TNF-alpha purification by heparin-Sepharose affinity chromatography. J\u00a0Chromatogr B Analyt Technol Biomed Life Sci 867(1):119\u2013125","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"10","key":"1153_CR16","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.4049\/jimmunol.165.10.5671","volume":"165","author":"RS Mummery","year":"2000","unstructured":"Mummery\u00a0RS, Rider\u00a0CC (2000) Characterization of the heparin-binding properties of IL\u20116. J\u00a0Immunol 165(10):5671\u20135679","journal-title":"J Immunol"},{"issue":"2","key":"1153_CR17","doi-asserted-by":"publisher","first-page":"L321","DOI":"10.1152\/ajplung.00337.2020","volume":"321","author":"L Chen","year":"2021","unstructured":"Chen\u00a0L, Kraft\u00a0BD, Roggli\u00a0VL, Healy\u00a0ZR, Woods\u00a0CW, Tsalik\u00a0EL, Ginsburg\u00a0GS, Murdoch\u00a0DM, Suliman\u00a0HB, Piantadosi\u00a0CA et\u00a0al (2021) Heparin-based blood purification attenuates organ injury in baboons with Streptococcus pneumoniae pneumonia. Am J Physiol Lung Cell Mol Physiol 321(2):L321\u2013L335","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"1153_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13054-022-04044-7","volume":"26","author":"G Eden","year":"2022","unstructured":"Eden\u00a0G, Schmidt\u00a0JJ, Buttner\u00a0S, Kumpers\u00a0P, Hafer\u00a0C, Rovas\u00a0A, Koch\u00a0BF, Schmidt\u00a0BMW, Kielstein\u00a0JT (2022) Safety and efficacy of the Seraph(R) 100 Microbind(R) Affinity Blood Filter to remove bacteria from the blood stream: results of the first in human study. Crit Care 26(1):181","journal-title":"Crit Care"},{"key":"1153_CR19","doi-asserted-by":"crossref","unstructured":"Seffer MT, Eden G, Engelmann S, Kielstein JT (2020) Elimination of Staphylococcus aureus from the bloodstream using a\u00a0novel biomimetic sorbent haemoperfusion device. BMJ Case Rep 13(8)","DOI":"10.1136\/bcr-2020-235262"},{"issue":"1","key":"1153_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s13054-022-04284-7","volume":"26","author":"C Monard","year":"2022","unstructured":"Monard\u00a0C, Tresson\u00a0P, Lamblin\u00a0A, Benatir\u00a0F, Taverna\u00a0XJ, Rimmele\u00a0T (2022) Intraoperative extracorporeal blood purification therapy during major septic vascular surgery. Crit Care 26(1):404","journal-title":"Crit Care"},{"key":"1153_CR21","doi-asserted-by":"crossref","unstructured":"Miller MK, Spiller RE, Mount CA, Colombo C, Khayat MI: Novel Use of Seraph-100 Blood Purification Therapy in Heat Stroke. Mil Med 2023, 188(1\u20132):407\u2013409.","DOI":"10.1093\/milmed\/usac124"},{"issue":"2","key":"1153_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/03913988221143142","volume":"46","author":"L Piscitani","year":"2023","unstructured":"Piscitani\u00a0L, Leone\u00a0S, Di Biase\u00a0J, Salvati\u00a0L, Sirolli\u00a0V, Tunno\u00a0M, Bonomini\u00a0M (2023) Efficacy of hemoperfusion with Seraph-100 in series with single pass albumin dialysis in acute hepatitis\u00a0B infection: A\u00a0case report. Int J Artif Organs 46(2):81\u201384","journal-title":"Int J Artif Organs"},{"key":"1153_CR23","doi-asserted-by":"crossref","unstructured":"Chitty SA, Mobbs S, Rifkin BS, Stogner SW, Lewis MS, Betancourt J, DellaVolpe J, Abouzahr F, Wilhelm AM, Szerlip HM et al: A\u00a0Multicenter Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19. Crit Care Explor 2022, 4(4):e0662.","DOI":"10.1097\/CCE.0000000000000662"},{"issue":"4","key":"1153_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/ndt\/gfab347","volume":"37","author":"JJ Schmidt","year":"2022","unstructured":"Schmidt\u00a0JJ, Borchina\u00a0DN, Van\u2019t Klooster\u00a0M, Bulhan-Soki\u00a0K, Okioma\u00a0R, Herbst\u00a0L, Rodriguez\u00a0DS, Premuzic\u00a0V, Buttner\u00a0S, Bader\u00a0B et\u00a0al (2022) Interim analysis of the COSA (COVID-19\u00a0patients treated with the Seraph(R) 100 Microbind(R) Affinity filter) registry. Nephrol Dial Transplant 37(4):673\u2013680","journal-title":"Nephrol Dial Transplant"},{"key":"1153_CR25","doi-asserted-by":"crossref","unstructured":"Kielstein JT, Borchina DN, Fuhner T, Hwang S, Mattoon D, Ball AJ: Hemofiltration with the Seraph((R)) 100 Microbind((R)) Affinity filter decreases SARS-CoV\u20112 nucleocapsid protein in critically ill COVID-19\u00a0patients. Crit Care 2021, 25(1):190.","DOI":"10.1186\/s13054-021-03597-3"},{"key":"1153_CR26","doi-asserted-by":"crossref","unstructured":"Andermatt R, Bloemberg GV, Ganter CC, Mueller NJ, Mueller AMS, Muellhaupt B, Kielstein JT, David S:\u00a0Elimination of Herpes Simplex Virus\u20112 and Epstein-Barr Virus With Seraph 100 Microbind Affinity Blood Filter and Therapeutic Plasma Exchange: An Explorative Study in a\u00a0Patient With Acute Liver Failure. Crit Care Explor 2022, 4(8):e0745.","DOI":"10.1097\/CCE.0000000000000745"},{"key":"1153_CR27","first-page":"10","volume":"1","author":"V Premuzic","year":"2023","unstructured":"Premuzic\u00a0V, Situm\u00a0I, Lovric\u00a0D, Erceg\u00a0A, Karmelic\u00a0D, Mogus\u00a0M, Jurjevic\u00a0M, Nedeljkovic\u00a0V, Mazar\u00a0M, Mihaljevic\u00a0S et\u00a0al (2023) Sequential Extracorporeal Blood Purification Is Associated with Prolonged Survival among ICU Patients with COVID-19 and Confirmed Bacterial Superinfection. Blood Purif 1:10","journal-title":"Blood Purif"},{"key":"1153_CR28","doi-asserted-by":"crossref","unstructured":"Seffer MT, Meyer TM, Borchina DN, Kielstein JT, Schmidt JJ (2024) Using the Seraph(R) 100 Microbind(R) Affinity blood filter under slow flow conditions through 18\u202fG and 16\u202fG central lines. J\u00a0Vasc Access 11297298241234073:","DOI":"10.1177\/11297298241234073"},{"issue":"3","key":"1153_CR29","first-page":"421","volume":"13","author":"JJ Schmidt","year":"2020","unstructured":"Schmidt\u00a0JJ, Eden\u00a0G, Seffer\u00a0MT, Winkler\u00a0M, Kielstein\u00a0JT (2020) In vitro elimination of anti-infective drugs by the Seraph((R)) 100 Microbind((R)) affinity blood filter. Clin Kidney\u00a0J 13(3):421\u2013424","journal-title":"Clin Kidney J"},{"key":"1153_CR30","doi-asserted-by":"crossref","unstructured":"DeLuca JP, Selig DJ, Vir P, Vuong CV, Della-Volpe J, Rivera IM, Park C, Levi B, Pratt KP, Stewart IJ (2024) Seraph 100 Microbind Affinity Blood Filter does not clear antibiotics: an analysis of antibiotic concentration data from PURIFY-OBS. Blood Purif","DOI":"10.1159\/000531951"},{"issue":"2","key":"1153_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/1744-9987.13549","volume":"25","author":"MT Seffer","year":"2021","unstructured":"Seffer\u00a0MT, Martens-Lobenhoffer\u00a0J, Schmidt\u00a0JJ, Eden\u00a0G, Bode-Boger\u00a0SM, Kielstein\u00a0JT (2021) Clearance of chloroquine and hydroxychloroquine by the Seraph(R) 100 Microbinda Affinity Blood Filter\u2014a device approved for the treatment of COVID-19\u00a0patients. Ther Apher Dial 25(2):237\u2013241","journal-title":"Ther Apher Dial"},{"issue":"8","key":"1153_CR32","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2215\/CJN.17601120","volume":"16","author":"JJ Schmidt","year":"2021","unstructured":"Schmidt\u00a0JJ, Bode-Boger\u00a0SM, Martens-Lobenhoffer\u00a0J, Hoeper\u00a0MM, Kielstein\u00a0JT (2021) Pharmacokinetics of Remdesivir and GS-441524 during PIRRT and Seraph 100 Therapy. Clin J Am Soc Nephrol 16(8):1256\u20131257","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1153_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1159\/000514523","volume":"50","author":"HRH de Geus","year":"2021","unstructured":"de Geus\u00a0HRH, Smeets\u00a0T, Hoek\u00a0RAS, Endeman\u00a0H, Hunfeld\u00a0N (2021) The Seraph(R)-100 Microbind Affinity Blood Filter Does Not Affect Vancomycin, Tacrolimus, and Mycophenolic Acid Plasma Concentrations. Blood Purif 50(6):971\u2013975","journal-title":"Blood Purif"},{"issue":"1","key":"1153_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000527290","volume":"13","author":"KA Merrill","year":"2023","unstructured":"Merrill\u00a0KA, Krallman\u00a0KA, Loeb\u00a0D, Standage\u00a0SW, Mattoon\u00a0D, Shan\u00a0D, Goldstein\u00a0SL, Schuh\u00a0MP (2023) First-Time Use of the Seraph((R)) 100 Microbind((R)) Affinity Blood Filter in an Adolescent Patient with Severe COVID-19 Disease: A\u00a0Case Report. Case Rep Nephrol Dial 13(1):1\u20136","journal-title":"Case Rep Nephrol Dial"},{"issue":"2","key":"1153_CR35","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1055\/s-0041-1727121","volume":"5","author":"A Pape","year":"2021","unstructured":"Pape\u00a0A, Kielstein\u00a0JT, Kruger\u00a0T, Fuhner\u00a0T, Brunkhorst\u00a0R (2021) Treatment of a\u00a0Critically Ill COVID-19\u00a0Patient with the Seraph 100 Microbind Affinity Filter. Th Open 5(2):e134\u2013e138","journal-title":"Th Open"},{"issue":"10","key":"1153_CR36","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1177\/08850666211039744","volume":"36","author":"MM Kelly","year":"2021","unstructured":"Kelly\u00a0MM, Wilkinson\u00a0JD, Rastegar\u00a0M, Lewis\u00a0MS, Betancourt\u00a0J (2021) Two Patients With Severe COVID Pneumonia Treated With the Seraph-100 Microbind Affinity Blood Filter. J\u00a0Intensive Care Med 36(10):1228\u20131232","journal-title":"J Intensive Care Med"},{"issue":"5","key":"1153_CR37","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/ckj\/sfab010","volume":"14","author":"D Sandoval","year":"2021","unstructured":"Sandoval\u00a0D, Rama\u00a0I, Quero\u00a0M, Hueso\u00a0M, Gomez\u00a0F, Cruzado\u00a0JM (2021) Treatment for severe COVID-19 with a\u00a0biomimetic sorbent haemoperfusion device in patients on haemodialysis. Clin Kidney\u00a0J 14(5):1475\u20131477","journal-title":"Clin Kidney J"},{"key":"1153_CR38","doi-asserted-by":"crossref","unstructured":"Olson SW, Oliver JD, Collen J, Bunin J, Gleeson TD, Foster BE, Simmons MP, Chen HW, Ficke JB, Brown TE et al: Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter. Crit Care Explor 2020, 2(8):e0180.","DOI":"10.1097\/CCE.0000000000000180"},{"key":"1153_CR39","doi-asserted-by":"crossref","unstructured":"Stoffel S, Boster J, Jarrett Z, Rosas M, Kalra A, Nugyen M, Morris M, Walter R:\u00a0Single-Center Experience With the Seraph-100(R) Microbind(R) Affinity Blood Filter in Patients With SARS-CoV\u20112 Infection and Septic Shock at a\u00a0Military Treatment Facility. Mil Med 2023.","DOI":"10.1093\/milmed\/usad063"},{"issue":"4","key":"1153_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3325\/cmj.2023.64.284","volume":"64","author":"M Pavlov","year":"2023","unstructured":"Pavlov\u00a0M, Bodrozic Dzakic Poljak\u00a0T, Pavlovic\u00a0N, Sestan Crnek\u00a0S, Baric\u00a0D, Rudez\u00a0I (2023) Enterobacter cloacae septicemia in a\u00a0triple-cannula extracorporeal membrane oxygenation circulatory support treated with Seraph-100 Microbind affinity blood filter. Croat Med\u00a0J 64(4):284\u2013288","journal-title":"Croat Med J"},{"issue":"2","key":"1153_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/03913988231221405","volume":"47","author":"V Votrico","year":"2024","unstructured":"Votrico\u00a0V, Grilli\u00a0M, Gerini\u00a0U, Berlot\u00a0G (2024) Hemoperfusion with high-affinity polyethylene microbeads (Seraph-100((R))) for the removal of pathogens in chronic critically ill patients: Clinical experience. Int J Artif Organs 47(2):115\u2013117","journal-title":"Int J Artif Organs"},{"issue":"1","key":"1153_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00467-023-06097-4","volume":"39","author":"DS Li","year":"2024","unstructured":"Li\u00a0DS, Burke\u00a0TM, Smith\u00a0JM, Reed\u00a0RC, Okamura\u00a0DM, Menon\u00a0S (2024) Use of the Seraph(R) 100 Microbind(R) Affinity Blood Filter in an adolescent patient with disseminated adenoviral disease. Pediatr Nephrol 39(1):331\u2013335","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"1153_CR43","doi-asserted-by":"publisher","first-page":"e1058","DOI":"10.1097\/CCE.0000000000001058","volume":"6","author":"SJ Amerson","year":"2024","unstructured":"Amerson\u00a0SJ, Hoffman\u00a0M, Abouzahr\u00a0F, Ahmad\u00a0M, Sterling\u00a0RK, Gidwani\u00a0H, Sousse\u00a0LE, Dellavolpe\u00a0JD (2024) Sequential Extracorporeal Therapy of Pathogen Removal Followed by Cell-Directed Extracorporeal Therapy in Streptococcal Toxic Shock Syndrome Refractory to Venoarterial Extracorporeal Membrane Oxygenation: A\u00a0Case. reportcrit Care Explor 6(3):e1058","journal-title":"reportcrit Care Explor"},{"key":"1153_CR44","doi-asserted-by":"crossref","unstructured":"Rifkin BS, Stewart IJ (2021) Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A\u00a0Case Series. Blood Purif: 1\u20134","DOI":"10.1159\/000517430"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01153-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-024-01153-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01153-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T16:34:10Z","timestamp":1745944450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-024-01153-9"}},"subtitle":["Seraph\u00ae 100 Microbind\u00ae Affinity Blood Filter und seine Anwendungsgebiete","Seraph\u00ae 100 Microbind\u00ae Affinity Blood Filter and its fields of application"],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1153"],"URL":"https:\/\/doi.org\/10.1007\/s00063-024-01153-9","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"23 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.-T.\u00a0Seffer gibt an, dass kein Interessenkonflikt besteht. J.T.\u00a0Kielstein erhielt Vortragshonorare von ExThera Medical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Dieser Beitrag stammt auszugsweise aus der Promotionsschrift von Malin-Theres Seffer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}